|
2111 |
Vorbereitungsstand zur EU Verordnung 536/2014 in den Mitgliedstaaten
Enthalten in Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz Bd. 60, 21.6.2017, Nr. 8, date:8.2017: 836-840
|
|
|
|
2112 |
Vorwort des 2. Vorsitzenden der ÄMM
Enthalten in Manuelle Medizin Bd. 55, 2.10.2017, Nr. 5, date:10.2017: 303-311
|
|
|
|
2113 |
‘We all want to succeed, but we’ve also got to be realistic about what is happening’: an ethnographic study of relationships in trial oversight and their impact
Enthalten in Trials Bd. 18, 22.12.2017, Nr. 1, date:12.2017: 1-16
|
|
|
|
2114 |
Welches ist das beste Migränemittel?
Enthalten in MMW - Fortschritte der Medizin Bd. 159, 25.10.2017, Nr. 18, date:10.2017: 32
|
|
|
|
2115 |
What are the main inefficiencies in trial conduct: a survey of UKCRC registered clinical trials units in the UK
Enthalten in Trials Bd. 19, 8.1.2018, Nr. 1, date:12.2018: 1-7
|
|
|
|
2116 |
Which risk understandings can be derived from the current disharmonized regulation of complementary and alternative medicine in Europe?
Enthalten in BMC complementary and alternative medicine Bd. 18, 10.1.2018, Nr. 1, date:12.2018: 1-7
|
|
|
|
2117 |
Who is willing to participate in low-risk pragmatic clinical trials without consent?
Enthalten in European journal of clinical pharmacology Bd. 73, 12.9.2017, Nr. 12, date:12.2017: 1557-1563
|
|
|
|
2118 |
Why prudence is needed when interpreting articles reporting clinical trial results in mental health
Enthalten in Trials Bd. 18, 28.3.2017, Nr. 1, date:12.2017: 1-4
|
|
|
|
2119 |
Why statistical inference from clinical trials is likely to generate false and irreproducible results
Enthalten in BMC medical research methodology Bd. 17, 22.8.2017, Nr. 1, date:12.2017: 1-12
|
|
|
|
2120 |
Wie bei Typ-2-Diabetes die Bereitschaft zur Insulintherapie erhöht werden kann
Enthalten in Info Diabetologie Bd. 12, 16.6.2018, Nr. 3, date:6.2018: 58
|
|
Administration
